PL357550A1 - Nowa postać galenowa molsydominy do podawania doustnego, o przedłużonym uwalnianiu - Google Patents

Nowa postać galenowa molsydominy do podawania doustnego, o przedłużonym uwalnianiu

Info

Publication number: PL357550A1
Authority: PL; Poland
Prior art keywords: molsidomine; hours; released; angina; galenical form
Prior art date: 2000-02-24

Application number

PL01357550A

Other languages

English (en)

Other versions

PL201631B1 (pl

Inventor

Jozsef-Michel Geczy

Original Assignee

Therabel Pharmaceuticals Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-02-24

Filing date

2001-02-22

Publication date

2004-07-26

2001-02-22 Application filed by Therabel Pharmaceuticals Limited filed Critical Therabel Pharmaceuticals Limited

2004-07-26 Publication of PL357550A1 publication Critical patent/PL357550A1/pl

2009-04-30 Publication of PL201631B1 publication Critical patent/PL201631B1/pl

Links

XLFWDASMENKTKL-UHFFFAOYSA-N molsidomine Chemical compound O1C(N=C([O-])OCC)=C[N+](N2CCOCC2)=N1 XLFWDASMENKTKL-UHFFFAOYSA-N 0.000 title abstract 10
229960004027 molsidomine Drugs 0.000 title abstract 10
230000002035 prolonged effect Effects 0.000 title 1
206010002383 Angina Pectoris Diseases 0.000 abstract 4
238000004090 dissolution Methods 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
239000002207 metabolite Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000001148 spastic effect Effects 0.000 abstract 1
238000013268 sustained release Methods 0.000 abstract 1
239000012730 sustained-release form Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Pulmonology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PL357550A 2000-02-24 2001-02-22 Doustny preparat galenowy molsydominy w postaci stałej o przedłużonym uwalnianiu PL201631B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0002307A FR2805462B1 (fr)	2000-02-24	2000-02-24	Nouvelle forme galenique orale a liberation prolongee de la molsidomine
PCT/EP2001/002055 WO2001062256A1 (fr)	2000-02-24	2001-02-22	Nouvelle forme galenique orale a liberation prolongee de la molsidomine

Publications (2)

Publication Number	Publication Date
PL357550A1 true PL357550A1 (pl)	2004-07-26
PL201631B1 PL201631B1 (pl)	2009-04-30

Family

ID=8847342

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL357550A PL201631B1 (pl)	2000-02-24	2001-02-22	Doustny preparat galenowy molsydominy w postaci stałej o przedłużonym uwalnianiu

Country Status (36)

Country	Link
US (1)	US7767227B2 (pl)
EP (1)	EP1265614B1 (pl)
JP (1)	JP4945043B2 (pl)
KR (1)	KR100814191B1 (pl)
CN (1)	CN100396284C (pl)
AT (1)	ATE296632T1 (pl)
AU (2)	AU2001240653B9 (pl)
BE (1)	BE1013487A3 (pl)
BG (1)	BG66111B1 (pl)
BR (1)	BRPI0108041B8 (pl)
CA (1)	CA2400886C (pl)
CZ (1)	CZ301993B6 (pl)
DE (1)	DE60111196T2 (pl)
DZ (1)	DZ3273A1 (pl)
EE (1)	EE05098B1 (pl)
ES (1)	ES2241803T3 (pl)
FR (1)	FR2805462B1 (pl)
HK (1)	HK1050138B (pl)
HR (1)	HRP20020692B1 (pl)
HU (1)	HU229799B1 (pl)
IL (2)	IL151205A0 (pl)
IS (1)	IS2446B (pl)
MA (1)	MA25576A1 (pl)
MD (1)	MD3119C2 (pl)
MX (1)	MXPA02008262A (pl)
NO (1)	NO329495B1 (pl)
NZ (1)	NZ520691A (pl)
OA (1)	OA12183A (pl)
PL (1)	PL201631B1 (pl)
PT (1)	PT1265614E (pl)
RS (1)	RS50291B (pl)
RU (1)	RU2263506C2 (pl)
SK (1)	SK286313B6 (pl)
UA (1)	UA73972C2 (pl)
WO (1)	WO2001062256A1 (pl)
ZA (1)	ZA200206042B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2805462B1 (fr) *	2000-02-24	2003-08-15	Therabel Res	Nouvelle forme galenique orale a liberation prolongee de la molsidomine
US7803402B2 (en) *	2002-07-06	2010-09-28	Sanjeev Khandelwal	Pharmaceutical preparations
FR2868314B1 (fr) *	2004-04-05	2008-10-24	Therabel Pharmaceuticals Ltd	Nouvelle utilisation therapeutique de la molsidomine et de ses sels pharmaceutiquement acceptables
EP2468269A1 (en)	2010-11-26	2012-06-27	Universitätsklinikum Münster	Nitric oxide donors in therapy of nitric oxide deficiency-induced disturbances of cerebral microcirculation
BE1028879B1 (fr)	2020-12-11	2022-07-12	Europharmaceuticals	Comprimé à libération prolongée de la molsidomine

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3522191A1 (de) *	1985-06-21	1987-01-15	Cassella Ag	Photostabilisierung von sydnoniminen
CN1006522B (zh) *	1986-04-30	1990-01-24	田道制药有限公司	缓放性制剂的制备方法
JP3078859B2 (ja) *	1990-02-23	2000-08-21	武田薬品工業株式会社	安定な放出制御性製剤用コーティング剤
HU210921B (en) *	1990-03-28	1995-09-28	Chinoin Gyogyszer Es Vegyeszet	Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
HU212730B (en) *	1990-03-28	1996-10-28	Chinoin Gyogyszer Es Vegyeszet	Process for producing inclusion complexes of cyclodextrine or its derivative and 3-morpholino-sydnonimine or its salt or its tautomer and pharmaceutical compositions containing them
DE4140192C2 (de) *	1991-12-05	1996-02-29	Alfatec Pharma Gmbh	Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen
EP0624370B1 (de) *	1993-05-11	1999-10-06	Hoechst Aktiengesellschaft	Galenische Zubereitungen von Molsidomin
WO1995001767A1 (en) *	1993-07-08	1995-01-19	Cygnus Therapeutic Systems	Monolithic matrix transdermal delivery system
IT1266565B1 (it) *	1993-07-22	1997-01-09	Ct Lab Farm Srl	Composizioni farmaceutiche a rilascio controllato a base di uno o piu' sali farmaceuticamente accettabili dell'acido gamma-idrossi-butirrico.
HU218280B (en) *	1994-04-26	2000-07-28		Cyclodextrin inclusion complexes containing sin-1a which are stable intheir solid state, process for their preparation and pharmaceutical compositions containing the comlexes
DE4443105C2 (de) *	1994-12-03	1997-03-13	Hoechst Ag	Verfahren zur Herstellung Molsidomin-haltiger Tabletten
JPH09114680A (ja) *	1995-10-19	1997-05-02	Fuji Xerox Co Ltd	シーケンス制御装置
IT1282576B1 (it) *	1996-02-06	1998-03-31	Jagotec Ag	Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
PE57198A1 (es) *	1996-03-25	1998-10-10	American Home Prod	Formula de liberacion prolongada
CA2302275C (en) *	1997-09-19	2009-12-08	Shire Laboratories, Inc.	Solid solution beadlet
FR2775188B1 (fr) *	1998-02-23	2001-03-09	Lipha	Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
FR2805462B1 (fr) *	2000-02-24	2003-08-15	Therabel Res	Nouvelle forme galenique orale a liberation prolongee de la molsidomine

2000
- 2000-02-24 FR FR0002307A patent/FR2805462B1/fr not_active Expired - Lifetime
2001
- 2001-02-22 PT PT01911692T patent/PT1265614E/pt unknown
- 2001-02-22 AT AT01911692T patent/ATE296632T1/de active
- 2001-02-22 DE DE60111196T patent/DE60111196T2/de not_active Expired - Lifetime
- 2001-02-22 OA OA1200200258A patent/OA12183A/fr unknown
- 2001-02-22 ES ES01911692T patent/ES2241803T3/es not_active Expired - Lifetime
- 2001-02-22 DZ DZ013273A patent/DZ3273A1/fr active
- 2001-02-22 CA CA2400886A patent/CA2400886C/fr not_active Expired - Lifetime
- 2001-02-22 NZ NZ520691A patent/NZ520691A/en not_active IP Right Cessation
- 2001-02-22 HK HK03102218.9A patent/HK1050138B/zh not_active IP Right Cessation
- 2001-02-22 EE EEP200200472A patent/EE05098B1/xx unknown
- 2001-02-22 BR BRPI0108041A patent/BRPI0108041B8/pt not_active IP Right Cessation
- 2001-02-22 CZ CZ20022876A patent/CZ301993B6/cs not_active IP Right Cessation
- 2001-02-22 BE BE2001/0121A patent/BE1013487A3/fr not_active IP Right Cessation
- 2001-02-22 CN CNB018052592A patent/CN100396284C/zh not_active Expired - Lifetime
- 2001-02-22 SK SK1220-2002A patent/SK286313B6/sk not_active IP Right Cessation
- 2001-02-22 WO PCT/EP2001/002055 patent/WO2001062256A1/fr not_active Ceased
- 2001-02-22 PL PL357550A patent/PL201631B1/pl unknown
- 2001-02-22 AU AU2001240653A patent/AU2001240653B9/en not_active Expired
- 2001-02-22 EP EP01911692A patent/EP1265614B1/fr not_active Expired - Lifetime
- 2001-02-22 HU HU0300607A patent/HU229799B1/hu unknown
- 2001-02-22 RU RU2002121503/15A patent/RU2263506C2/ru active
- 2001-02-22 HR HR20020692A patent/HRP20020692B1/xx not_active IP Right Cessation
- 2001-02-22 MD MDA20020212A patent/MD3119C2/ro active IP Right Grant
- 2001-02-22 KR KR1020027010441A patent/KR100814191B1/ko not_active Expired - Lifetime
- 2001-02-22 RS YUP-622/02A patent/RS50291B/sr unknown
- 2001-02-22 AU AU4065301A patent/AU4065301A/xx active Pending
- 2001-02-22 US US10/182,718 patent/US7767227B2/en not_active Expired - Fee Related
- 2001-02-22 JP JP2001561321A patent/JP4945043B2/ja not_active Expired - Lifetime
- 2001-02-22 MX MXPA02008262A patent/MXPA02008262A/es active IP Right Grant
- 2001-02-22 IL IL15120501A patent/IL151205A0/xx active IP Right Grant
- 2001-02-22 UA UA2002086983A patent/UA73972C2/uk unknown
2002
- 2002-07-29 ZA ZA200206042A patent/ZA200206042B/xx unknown
- 2002-08-06 MA MA26765A patent/MA25576A1/fr unknown
- 2002-08-12 IL IL151205A patent/IL151205A/en unknown
- 2002-08-14 IS IS6504A patent/IS2446B/is unknown
- 2002-08-22 BG BG107027A patent/BG66111B1/bg unknown
- 2002-08-23 NO NO20024043A patent/NO329495B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL151205A (en)	2011-01-31
MD3119B2 (en)	2006-08-31
BR0108041B1 (pt)	2013-06-18
HUP0300607A3 (en)	2006-02-28
EE05098B1 (et)	2008-12-15
MD3119C2 (ro)	2007-04-30
IS2446B (is)	2008-11-15
CN1419451A (zh)	2003-05-21
NO329495B1 (no)	2010-11-01
RU2002121503A (ru)	2004-03-20
HK1050138B (zh)	2005-07-29
JP4945043B2 (ja)	2012-06-06
HK1050138A1 (en)	2003-06-13
WO2001062256A1 (fr)	2001-08-30
FR2805462B1 (fr)	2003-08-15
NO20024043D0 (no)	2002-08-23
MD20020212A (en)	2002-12-31
HRP20020692B1 (en)	2011-10-31
OA12183A (fr)	2006-05-09
AU2001240653B9 (en)	2005-10-27
CA2400886C (fr)	2011-04-19
BR0108041A (pt)	2002-10-29
CA2400886A1 (fr)	2001-08-30
DE60111196D1 (de)	2005-07-07
EP1265614B1 (fr)	2005-06-01
MA25576A1 (fr)	2002-10-01
ES2241803T3 (es)	2005-11-01
HUP0300607A2 (hu)	2003-08-28
UA73972C2 (en)	2005-10-17
CZ301993B6 (cs)	2010-09-01
JP2003523981A (ja)	2003-08-12
KR100814191B1 (ko)	2008-03-17
BRPI0108041B8 (pt)	2021-05-25
BG107027A (bg)	2003-04-30
MXPA02008262A (es)	2004-04-05
YU62202A (sh)	2006-01-16
CN100396284C (zh)	2008-06-25
EP1265614A1 (fr)	2002-12-18
AU2001240653B2 (en)	2005-05-26
BG66111B1 (bg)	2011-05-31
FR2805462A1 (fr)	2001-08-31
SK286313B6 (en)	2008-07-07
DZ3273A1 (fr)	2001-08-30
HU229799B1 (en)	2014-07-28
US7767227B2 (en)	2010-08-03
SK12202002A3 (sk)	2002-12-03
NZ520691A (en)	2004-07-30
IL151205A0 (en)	2003-04-10
DE60111196T2 (de)	2006-05-11
IS6504A (is)	2002-08-14
ATE296632T1 (de)	2005-06-15
BE1013487A3 (fr)	2002-02-05
ZA200206042B (en)	2003-07-29
RU2263506C2 (ru)	2005-11-10
US20030045522A1 (en)	2003-03-06
HRP20020692A2 (en)	2004-02-29
RS50291B (sr)	2009-09-08
PL201631B1 (pl)	2009-04-30
EE200200472A (et)	2003-12-15
KR20020081323A (ko)	2002-10-26
NO20024043L (no)	2002-08-23
PT1265614E (pt)	2005-10-31
AU4065301A (en)	2001-09-03

Publication	Publication Date	Title
MY142204A (en)	2010-10-29	Pramipexole once-daily dosage form
RU2005115855A (ru)	2006-01-20	Композиция трамадола продлонгированного высвобождением с 24-часовым действием
ATE333265T1 (de)	2006-08-15	Oral anzuwendende schnell zerfallende feste darreichungsformen
CA2476201A1 (en)	2003-09-04	Modified release formulations of at least one form of tramadol
JO2555B1 (en)	2010-09-05	Forms of oral doses of propiferine or pharmaceutically acceptable salts thereof with an extended release of active agent
MY126555A (en)	2006-10-31	Oral pharmaceutical extended release dosage form
MX2009001711A (es)	2009-05-08	Formulaciones de liberacion sostenida de topiramato.
TW200505498A (en)	2005-02-16	Sugar-free oral transmucosal solid dosage forms and uses thereof
GB2395434A (en)	2004-05-26	Composition for reducing appetite in mammals comprising proxyanidin
CA2415154A1 (en)	2004-06-24	Modified release formulations of selective serotonin re-uptake inhibitors
HRP20020692A2 (en)	2004-02-29	Novel galenical form for oral administration with prolonged release of molsidomine
MXPA05008843A (es)	2005-10-18	Sistema terapeutico que comprende amoxicilina y acido clavulanico.
WO2007010559A3 (en)	2007-09-20	Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor
JP2004522780A5 (pl)	2006-01-05
ITMI20080798A1 (it)	2009-09-11	Composizione a rilascio modificato a base di doxofillina
CY1105168T1 (el)	2010-03-03	Διφασικη συνθεση με τραμαδολη
IT1293835B1 (it)	1999-03-10	Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione
NO20032581L (no)	2003-06-06	Farmasöytisk formulering av gepiron for oral administrering
HRP20160479T1 (hr)	2016-06-03	Oralni pripravak molsidomina s produljenim otpuštanjem, namijenjen liječenju ateroskleroze
NZ521515A (en)	2004-12-24	Composition comprising paracetamol and niflumic acid